Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study

SIMPLE SUMMARY: In this study, the rate of hepatocellular carcinoma (HCC) recurrence (HCC-R) after hepatitis C virus eradication by direct-acting antiviral (DAA) treatment was relatively high, corresponding to 63.8% (83/130) of the studied cases. The patients who electively received palliative treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tani, Joji, Senoh, Tomonori, Moriya, Akio, Ogawa, Chikara, Deguchi, Akihiro, Sakamoto, Teppei, Takuma, Kei, Nakahara, Mai, Oura, Kyoko, Tadokoro, Tomoko, Mimura, Shima, Fujita, Koji, Yoneyama, Hirohito, Kobara, Hideki, Morishita, Asahiro, Himoto, Takashi, Tsutsui, Akemi, Nagano, Takuya, Takaguchi, Koichi, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125844/
https://www.ncbi.nlm.nih.gov/pubmed/34066708
http://dx.doi.org/10.3390/cancers13092257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125844/
https://www.ncbi.nlm.nih.gov/pubmed/34066708
http://dx.doi.org/10.3390/cancers13092257

Ejemplares similares